You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

M21NSC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))

Completed
  • Melanoma (Skin)
  • MART-1
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Healthy Women of Child Bearing Potential Trial (R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline)

Not yet recruiting
  • Healthy Women of Child Bearing Potential
  • R21/Matrix-M1
  • +2 more
  • (no location specified)
Oct 10, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Malaria Trial (R21/Matrix-M™)

Recruiting
  • Malaria
  • R21/Matrix-M™
  • Entebbe, Uganda
    MRC/UVRI & LSHTM Uganda Research Unit
Jan 13, 2023

Healthy Participants Trial in Toronto (Lucid-21-302, Placebo)

Recruiting
  • Healthy Participants
  • Toronto, Ontario, Canada
    Biopharma Services Incorporated
Apr 6, 2023

Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)

Not yet recruiting
  • Malaria, Plasmodium Falciparum
  • Matrix-M with RH5.2 VLP and/or R21
  • (no location specified)
Oct 21, 2022

Mental Health Trial in Manchester (Single-Session Method of Levels Intervention)

Not yet recruiting
  • Mental Health
  • Single-Session Method of Levels Intervention
  • Manchester, Greater Manchester, United Kingdom
  • +1 more
Sep 25, 2023

Triple Negative Breast Cancer Trial in Guangzhou (Gemcitabine and carboplatin plus antibiotic (moxifloxacin), Gemcitabine

Recruiting
  • Triple Negative Breast Cancer
  • Gemcitabine and carboplatin plus antibiotic (moxifloxacin)
  • Gemcitabine combined with carboplatin plus placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 6, 2022

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in United

Completed
Has Results
  • Adult Acute Basophilic Leukemia
  • +16 more
  • Little Rock, Arkansas
  • +53 more
Jan 13, 2022

Influenza Trial in Raleigh, Rocky Mount, Statesville (NanoFlu, Fluzone HD - Day 0, Fluzone HD - Day 21)

Completed
Has Results
  • Influenza
  • NanoFlu
  • +3 more
  • Raleigh, North Carolina
  • +2 more
Nov 29, 2022

Allergic Rhinitis Trial in Toronto (AllerPops)

Completed
  • Allergic Rhinitis
  • AllerPops
  • Toronto, Ontario, Canada
    Dicentra
Jul 20, 2023

Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2023

Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in

Active, not recruiting
  • Recurrent Glioblastoma Multiforme
  • +2 more
  • M032 (NSC 733972)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 26, 2022

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

Malaria,Falciparum Trial in Bangkok (R21/Matrix-M vaccination, DHA-PIP, PQ)

Not yet recruiting
  • Malaria,Falciparum
  • R21/Matrix-M vaccination
  • +2 more
  • Bangkok, Thailand
    Hospital for Tropical Diseases, Faculty of Tropical Medicine, Ma
Feb 22, 2022

Squamous Cell Carcinoma of Larynx Trial in São Paulo (carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v.

Recruiting
  • Squamous Cell Carcinoma of Larynx
  • carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v. on day 1, every 21 days for 3 cycles
  • +2 more
  • São Paulo, Brazil
    Beneficiencia Portuguesa de São Paulo/Hospital São José
Dec 22, 2022

Malaria,Falciparum Trial in Kilifi (R21/Matrix-M, ChAd63/MVA ME-TRAP, intradermal injection (ID) or direct venous injection

Recruiting
  • Malaria,Falciparum
  • R21/Matrix-M
  • +2 more
  • Kilifi, Kenya
    KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine R
Sep 14, 2022

Malaria,Falciparum Trial in Kilifi (R21 in Matrix- M adjuvant vaccine)

Completed
  • Malaria,Falciparum
  • R21 in Matrix- M adjuvant vaccine
  • Kilifi, Kenya
    KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine R
Aug 19, 2022

Plasmodium Falciparum Malaria Trial in Bandarban, Lama (DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-M™)

Not yet recruiting
  • Plasmodium Falciparum Malaria
  • DHA/piperaquine and a SLD-PQ
  • Study vaccine R21/Matrix-M™
  • Bāndarban, Bangladesh
  • +1 more
Sep 28, 2023

Malaria Trial in Oxford (R21/Matrix-M, Rabies vaccine)

Active, not recruiting
  • Malaria
  • R21/Matrix-M
  • Rabies vaccine
  • Oxford, United Kingdom
    CCVTM, University of Oxford, Churchill Hospital
Jan 26, 2022

Inflammation, Vaccine, Intestinal Permeability Trial in Davis (Inulin, Maltodextrin, Ty21a Typhoid Fever Vaccine)

Recruiting
  • Inflammation
  • +3 more
  • Inulin
  • +2 more
  • Davis, California
    USDA, ARS, Western Human Nutrition Research Center
Nov 29, 2022

Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

Recruiting
  • Lung Cancer
  • AMG 510
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Atherosclerotic Cardiovascular Disease Trial in Worldwide (Placebo, Olpasiran)

Recruiting
  • Atherosclerotic Cardiovascular Disease
  • Huntsville, Alabama
  • +83 more
Feb 1, 2023

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • trebananib
  • +3 more
  • Buffalo, New York
  • +1 more
Sep 8, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023